// App-Quantinova.ai

: Evaluation of the steroid sparing effects of Mepolizumab using the Glucocorticoid Toxicity Index

Researchers

Presenter

  • Pamela Jane McDowell

Principal Investigators

  • John Stone

  • Kirsty Honeyford

  • Louise Dunn

  • R Jayne Logan

  • Claire A Butler

  • Liam Heaney

Medical Centers

  • Centre for Experimental Medicine, School of Medicine, Dentistry & Biological Sciences, Queen’s University Belfast, UK , Belfast, United Kingdom

  • Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

  • Department of Respiratory Medicine, Belfast City Hospital; Belfast Health and Social Care Trust, Northern Ireland, Belfast, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • Glucocorticoid

  • Mepolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved